Literature DB >> 7815483

Epstein-Barr virus latent messages with shuffled leader exons: remnants of circumgenomic transcription?

L Qu1, D T Rowe.   

Abstract

The EBNA transcription unit which is active in Epstein-Barr virus-immortalized latently infected B lymphocytes covers approximately 60% of the 172-kb genome. Since the genome exists as a circular double-stranded DNA molecule in latently infected cells, it is conceivable that complete copies are made during transcription. Rather than attempt to detect gigantic RNA molecules directly, we used RNA-PCR to detect incorporation of leader exons into mRNA in a shuffled order. The downstream U leader exon was detected spliced upstream of the internal repeat leader exons W1 and W2 in the polyadenylated RNA fraction of spontaneous lymphoblastoid cell lines, restricted phenotype BL cell lines Wanyanyi and Wewak2, and in B95-8, Raji, and Akata cells. Quantitative competitive RNA-PCR showed that the ratio of U exon-containing EBNA1 messages to U exon-shuffled leader messages was approximately 10:1, with large variation from cell line to cell line, and was not affected by induction of the lytic cycle in B95-8, Raji, or Akata cells. Messages with shuffled exons contained only the C2W1 alternative splice, which does not produce an initiator AUG methionine codon for EBNA4 gene expression. The results provide evidence for long-range exon skipping and imply that genome-length transcripts may occur and participate in viral gene expression in latency.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7815483      PMCID: PMC188676     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.

Authors:  J Luka; B Kallin; G Klein
Journal:  Virology       Date:  1979-04-15       Impact factor: 3.616

2.  Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth.

Authors:  N Lewin; P Aman; M G Masucci; E Klein; G Klein; B Oberg; H Strander; W Henle; G Henle
Journal:  Int J Cancer       Date:  1987-04-15       Impact factor: 7.396

3.  Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis.

Authors:  G Miller; J C Niederman; L L Andrews
Journal:  N Engl J Med       Date:  1973-02-01       Impact factor: 91.245

4.  Kinetics and efficiency of polyadenylation of late polyomavirus nuclear RNA: generation of oligomeric polyadenylated RNAs and their processing into mRNA.

Authors:  N H Acheson
Journal:  Mol Cell Biol       Date:  1984-04       Impact factor: 4.272

5.  Paired Epstein-Barr virus-carrying lymphoma and lymphoblastoid cell lines from Burkitt's lymphoma patients: comparative sensitivity to non-specific and to allo-specific cytotoxic responses in vitro.

Authors:  C M Rooney; A B Rickinson; D J Moss; G M Lenoir; M A Epstein
Journal:  Int J Cancer       Date:  1984-09-15       Impact factor: 7.396

6.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

7.  Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region.

Authors:  D R Rawlins; G Milman; S D Hayward; G S Hayward
Journal:  Cell       Date:  1985-10       Impact factor: 41.582

8.  Endemic Burkitt's lymphoma: phenotypic analysis of tumor biopsy cells and of derived tumor cell lines.

Authors:  C M Rooney; C D Gregory; M Rowe; S Finerty; C Edwards; H Rupani; A B Rickinson
Journal:  J Natl Cancer Inst       Date:  1986-09       Impact factor: 13.506

9.  Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells.

Authors:  D T Rowe; M Rowe; G I Evan; L E Wallace; P J Farrell; A B Rickinson
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

10.  Transcription of woodchuck hepatitis virus in the chronically infected liver.

Authors:  T Möröy; J Etiemble; C Trépo; P Tiollais; M A Buendia
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.